ETF PROAI

IBBQvsIVV

Invesco Nasdaq Biotechnology ETF against iShares Core S&P 500 ETF — the fee, the flows, the book, and a year head-to-head.

One year, growth of $100
IBBQ 137IVV 115Oct 25Oct 26GROWTH OF $100
Head to head
IBBQIVV
Expense ratio0.19%0.030%
Assets$106M$882.6B
Net flow, 1 month+$12M−$4.7B
Net flow, 1 year+$48M+$69.9B
Return, YTD+21.0%+12.9%
Return, 1 year+37.0%+15.0%
Avg daily volume40K9.9M
Holdings219507
ListedJun 11, 2021May 15, 2000
Options marketYesYes

MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS

THE DESK BRIEF

Flows, fee cuts, and closure risk on the funds you watch — every trading morning.